GlaxoSmithKline
NYSE: GSK
The 3 Deadliest Diseases in the U.S.
These deadly diseases kill more than 1 million Americans every year. But there's still some good news.
Clinical data and abstracts abound ahead of the American Society of Clinical Oncology's annual meeting.
3 Most Important Upcoming FDA Decisions of 2013
The Food and Drug Administration will decide on drugs developed by Merck, Antares Pharmaceuticals, and GlaxoSmithKline in the coming months.Is AstraZeneca Gearing Up for a Shopping Spree?
With the company's pipeline in turmoil, AstraZeneca looks into the acquisition game.